University Of North Carolina At Chapel Hill CRLX030A2209 — Chapel Hill, North Carolina

University Of North Carolina At Chapel Hill CRLX030A2209 is a clinical research site located in Chapel Hill, North Carolina, United States 27599-7075.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University Of North Carolina At Chapel Hill CRLX030A2209 has participated in 1 clinical trials.

Therapeutic areas: Heart Failure With Preserved Ejection Fraction (HFpEF).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University Of North Carolina At Chapel Hill CRLX030A2209?

University Of North Carolina At Chapel Hill CRLX030A2209 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University Of North Carolina At Chapel Hill CRLX030A2209 conducted?

University Of North Carolina At Chapel Hill CRLX030A2209 has 1 clinical trials on record. Their work covers Heart Failure With Preserved Ejection Fraction (HFpEF).

Is University Of North Carolina At Chapel Hill CRLX030A2209 accredited by Crixeo Health?

University Of North Carolina At Chapel Hill CRLX030A2209 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University Of North Carolina At Chapel Hill CRLX030A2209?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.